Vita Coco Insider Sale: 20,000 Shares Sold Under 10b5-1; 1.1M Options Disclosed
Rhea-AI Filing Summary
Vita Coco insider Form 4: Martin Roper stock sales and option holdings. The filing reports that Martin Roper, CEO and director, sold four blocks of common stock on 09/18/2025 pursuant to a Rule 10b5-1 trading plan, disposing of 5,000 shares in his name and 5,000 shares each tied to three family trusts for a total reported disposals of 20,000 shares at weighted average prices around $40.00–$40.11 per share. The filing also discloses substantial currently exercisable and non-exercisable non-qualified stock options totaling 1,098,460 underlying shares across multiple grants with exercise prices ranging from $10.178 to $32.78.
Positive
- Sales executed under a Rule 10b5-1 trading plan, indicating pre-established, documented trading instructions
- Substantial option holdings disclosed totaling 1,098,460 underlying shares across multiple grants, showing retained insider equity upside
- Clear ownership disclosure separating direct holdings and indirect holdings via family trusts and spouse
Negative
- Reported disposals of 20,000 common shares on 09/18/2025 at weighted average prices around $40.00–$40.11
- Potential future dilution from large option pools with exercise prices as low as $10.178
Insights
TL;DR: Insider sold 20,000 shares under a 10b5-1 plan while retaining over one million potential shares through stock options.
The sale of 20,000 common shares by Martin Roper was executed pursuant to a Rule 10b5-1 plan, which documents pre-established trading and typically mitigates concerns about opportunistic timing. Reported weighted average sale prices ranged from approximately $40.00 to $40.11. The filing also shows material option holdings: multiple grants aggregate to 1,098,460 underlying shares, including large fully vested, exercisable options at $10.178 and multi-year grants with higher strike prices. For investors, the key facts are the existence of the trading plan and the sizable option positions that preserve potential future insider equity dilution and incentive alignment.
TL;DR: Disclosure follows governance best practices: 10b5-1 plan sales and clear identification of direct and trust ownership.
The Form 4 identifies Martin Roper as both CEO and a director and discloses sales executed under a documented 10b5-1 trading plan, enhancing disclosure transparency. Ownership is reported as a mix of direct and indirect (family trusts and spouse), and the filing specifies vesting schedules for option grants. These details enable shareholders to assess insider alignment and timing controls. No amendments or atypical transactions are reported beyond routine option holdings and plan-based sales.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 5,000 | $40.006 | $200K |
| Sale | Common Stock | 5,000 | $40.009 | $200K |
| Sale | Common Stock | 5,000 | $40.011 | $200K |
| Sale | Common Stock | 5,000 | $40.007 | $200K |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.10, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.10, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. These shares are held by the Christopher G. Roper Exempt Family Trust. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.11, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. These shares are held by the Peter S. Roper Exempt Family Trust. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.09, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. These shares are held by the Thomas L. Roper Exempt Family Trust. The stock option is fully vested and currently exercisable. The stock option is fully vested and currently exercisable. The stock option vests in four equal annual installments beginning on November 27, 2022. The stock option vests in four equal annual installments beginning on March 10, 2024. The stock option vests in four equal annual installments beginning on March 4, 2025. The Stock Option vests in four equal annual installments beginning in March 3, 2026.
